Sildenafil/Metformin/Leucine

西地那非/二甲双胍/亮氨酸

Report date: 2022/07/19 20:00:45

Base Information

Drug NameSildenafil/Metformin/Leucine
Drug Alias NameLeucine/Metformin/Sildenafil二甲双胍/亮氨酸/西地那非Leucine/Sildenafil/Metformin亮氨酸/西地那非/二甲双胍/Metformin/Leucine/Sildenafil +[7] 
ClassificationSmall molecules
Mechanisms of ActionProtein kinase AMP-activated non-catalytic subunit beta 1 activatorsPhosphodiesterase 5A inhibitors
TargetsProtein kinase AMP-activated non-catalytic subunit beta 1Phosphodiesterase 5A
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes Metformin HydrochlorideSildenafil Citrate
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNusirt Biopharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNusirt Biopharma
Active IndicationsN/A
Inactive IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease

Other Information

ATC CodeN/A
Related LinksN/A